Kohler S, Asadov D A, Bründer A, Healy S, Khamraev A K, Sergeeva N, Tinnemann P
Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Department of Health Management, Evidence-based Medicine Centre, Tashkent Institute of Postgraduate Medical Education, Tashkent.
Int J Tuberc Lung Dis. 2014 Dec;18(12):1390-5. doi: 10.5588/ijtld.14.0190.
The tuberculosis (TB) control strategy in the Republic of Karakalpakstan, Uzbekistan, is being changed to decentralised out-patient care for most TB patients by the Government of Uzbekistan, in collaboration with the international medical humanitarian organisation Médecins Sans Frontières. Ambulatory treatment of both drug-susceptible and drug-resistant TB from the first day of treatment has been recommended since 2011. Out-patient treatment of TB from the beginning of treatment was previously prohibited. However, the current Uzbek health financing system, which evolved from the Soviet Semashko model, offers incentives that work against the adoption of ambulatory TB treatment. Based on the 'Comprehensive TB Care for All' programme implemented in Karakalpakstan, we describe how existing policies for the allocation of health funds complicate the scale-up of ambulatory-based management of TB.
乌兹别克斯坦政府与国际医疗人道主义组织无国界医生合作,将在卡拉卡尔帕克斯坦共和国实施的结核病控制策略转变为为大多数结核病患者提供去中心化的门诊护理。自2011年起,就建议从治疗第一天起对药物敏感和耐药结核病患者进行门诊治疗。此前,从治疗开始就禁止对结核病患者进行门诊治疗。然而,目前从苏联的谢马什科模式演变而来的乌兹别克斯坦卫生筹资系统提供的激励措施不利于采用门诊结核病治疗。基于在卡拉卡尔帕克斯坦实施的“全民综合结核病护理”计划,我们描述了现有的卫生资金分配政策如何使基于门诊的结核病管理的扩大复杂化。